Cargando…
Can molecular targeting the TNFα-ERK-ETS1-IL27Rα pathway keep us young and healthy by protecting HSCs from aging?
Autores principales: | He, Yonghan, Zhou, Daohong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975103/ https://www.ncbi.nlm.nih.gov/pubmed/35400025 http://dx.doi.org/10.1097/BS9.0000000000000060 |
Ejemplares similares
-
Differences of plasma IL-1 and TNF-α in healthy Chinese Population
por: Yuan, Jintao, et al.
Publicado: (2015) -
Behҫet’s Disease, and the Role of TNF-α and TNF-α Blockers
por: van der Houwen, Tim, et al.
Publicado: (2020) -
The synergistic effect of sorafenib and TNF-α inhibitor on hepatocellular carcinoma
por: Wang, Mingda, et al.
Publicado: (2019) -
ERK2 and JNK1 contribute to TNF-α-induced IL-8 expression in synovial fibroblasts
por: Namba, Shinichi, et al.
Publicado: (2017) -
Anti-TNF-α therapy as a clinical intervention for periprosthetic osteolysis
por: Schwarz, Edward M, et al.
Publicado: (2000)